Pancreatitis clinical trials at UCSF
3 in progress, 2 open to eligible people

• A Prospective Observational Study of TPIAT

  open to all eligible people

  Multi-center, prospective, observational cohort study of patients undergoing total pancreatectomy with islet autotransplantation (TPIAT)

  San Francisco, California and other locations

• Pediatric Longitudinal Cohort Study of Chronic Pancreatitis

  open to eligible people ages up to 17 years

  The investigators will enroll a total of 628 patients under 18 years of age with ARP or CP. Included in the total are the 357patients in the INSPPIRE 1 database who are planned to be reenrolled under this protocol over the next 4 years. Patient questionnaires and physician surveys will be applied at the time of enrollment and annually thereafter as long as possible. At the first study visit after turning 18 years of age, the patient will sign the informed consent to continue in the study. Specifically, the investigators will define the demographics of the pediatric ARP and CP cohort, describe risk factors, presence of family history of acute and chronic pancreatitis, diabetes and pancreatic cancer and assess disease burden and sequelae.

  San Francisco, California and other locations

• A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis

  Sorry, not yet accepting patients

  Determine if IV ketorolac is an effective agent in the prevention of post-ERCP pancreatitis. Determine if IV ketorolac provides improved post-procedure analgesia. Determine if systemic mediators of inflammation are reduced in patients receiving IV ketorolac following ERCP.

  San Francisco, California and other locations

Last updated: October 30, 2019